Recruiting
Cutaneous T-cell lymphoma recurrent+1
RecruitingA Study of PTX-100 for Patients with Cutaneous T-Cell Lymphoma That Has Returned or Did Not Respond to Previous Treatment
InvestigationalNo placebo
A Study of PTX-100 for Patients with Cutaneous T-Cell Lymphoma That Has Returned or Did Not Respond to Previous Treatment
InvestigationalNo placebo
- Disease:Cutaneous T-cell lymphoma recurrentCutaneous T-cell lymphoma refractory
- Substances:PTX-100 trihydrate
Countries:
France
France- Participants:18–64 years · 65+ years
- Substances:PTX-100 trihydrate
